Proteome Sciences plc (LON:PRM) insider Martin Diggle purchased 313,957 shares of the firm’s stock in a transaction that occurred on Thursday, November 8th. The stock was purchased at an average price of GBX 3 ($0.04) per share, with a total value of £9,418.71 ($12,307.21).

LON:PRM opened at GBX 3.53 ($0.05) on Wednesday. Proteome Sciences plc has a one year low of GBX 2.61 ($0.03) and a one year high of GBX 5.64 ($0.07).

Separately, FinnCap reiterated a “corporate” rating on shares of Proteome Sciences in a research note on Tuesday, November 6th.

ILLEGAL ACTIVITY NOTICE: “Proteome Sciences plc (PRM) Insider Buys £9,418.71 in Stock” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The original version of this piece of content can be viewed at

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers. It delivers content for personalized medicine in the areas of biomarker services, biomarker assays, isobaric and isotopic reagents, and proprietary biomarkers. The company designs, performs, and interprets high resolution proteomics studies to improve target discovery, validation, and mechanism of action studies; offers specialized services to enhance discovery and validation of mechanistic biomarkers in peripheral fluids; and provides a set of bioinformatics tools to enhance data integration, and select regulated features and map to biological processes.

See Also: The risks of owning bonds

Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with's FREE daily email newsletter.